LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value of $89.66 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling Maturity, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value $89.66M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value $237.00M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value $195.19M.
- 2025-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value $6.08M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value |
|---|---|
| 2026-06-30 | $89.66M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $237.00M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $195.19M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $6.08M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.71M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $4.66M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $14.02M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $18.34M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $6.93M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.82M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $10.96M 10-Q · filed 2023-05-08 |
| 2022-09-30 | $939.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.13M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.40M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $23.40M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $23.32M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $23.51M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $21.95M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $73.51M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $71.19M 10-Q · filed 2020-05-08 |